Does this patient need an extensive ALS work‑up, or can we limit evaluation to a focused neurological assessment?

ALS Workup: Focused Evaluation is Appropriate

For a patient who has already undergone extensive evaluation, a focused neurological assessment with limited imaging is sufficient—extensive additional workup is not necessary and may cause unnecessary burden.

Rationale for Limited Workup

The diagnosis of ALS remains fundamentally clinical, with imaging serving primarily to exclude mimics rather than confirm the diagnosis 1. The ACR Appropriateness Criteria (2020) explicitly states that "imaging relied upon mainly to exclude other conditions with similar clinical presentations rather than confirm or facilitate the diagnosis of ALS" 1.

Essential Diagnostic Components

Core diagnostic tests that should be completed (if not already done):

• Electromyography (EMG) and nerve conduction studies - These are the "key tests in diagnosing ALS" and are essential for confirming upper and lower motor neuron involvement 1
• MRI brain without contrast - This is "usually appropriate" but serves to exclude structural lesions, not to diagnose ALS 1
• Clinical examination documenting both upper motor neuron signs (hypertonicity, hyperreflexia) and lower motor neuron signs (fasciculations, weakness, atrophy) 1

What NOT to Pursue

The following are explicitly NOT recommended and should be avoided:

• FDG-PET/CT brain - "no relevant literature to support" its use 1
• MR spectroscopy - "no relevant literature to support" its use 1
• Functional MRI (fMRI) - "no relevant literature to support" its use 1
• CT imaging (brain or spine) - "not useful" due to limited soft-tissue characterization 1
• MRI spine - "often normal early in disease" and only appropriate "in certain clinical circumstances" to exclude structural/infectious/neoplastic mimics 1

Patient-Centered Considerations

Given that this patient "has already been through a lot," the principle of minimizing unnecessary testing is paramount. ALS has a median survival of 3-4 years from symptom onset 1, making it critical to avoid diagnostic delays while also preventing the physical and emotional burden of excessive testing.

Key Clinical Pitfalls to Avoid

1. Over-imaging: The most common MRI findings in ALS (T2/FLAIR signal changes in corticospinal tracts, hypointensity in precentral gyrus) are supportive but not diagnostic 1

2. Delaying diagnosis: The typical time to diagnosis is already 10-16 months from symptom onset 2, and "early diagnosis should be pursued" 3

3. Unnecessary procedures: Misdiagnosis often results in "unnecessary procedures and surgeries" 2

Recommended Approach

If the patient has already had:

• Comprehensive neurological examination showing upper and lower motor neuron signs
• EMG/nerve conduction studies confirming widespread denervation
• Brain MRI excluding structural lesions

Then no further workup is needed. Focus should shift immediately to:

• Initiating riluzole "as early as possible" 3
• Establishing multidisciplinary care 3
• Screening for dysphagia (should occur every 3 months) 4
• Discussing advance directives early 3

The evidence strongly supports that additional testing beyond the essentials provides no diagnostic benefit and delays critical supportive care that is known to improve both survival and quality of life 3.